Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The substances improved hair regrowth and protected hair cells in humans and mice.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Constant light exposure during pregnancy changes newborn rabbits' skin, affecting hair follicles, skin thickness, and pigment cells.

Certain supplements, like whey protein isolate and growth hormones, can worsen hair loss.

Facelifts for Asians are challenging due to thicker, heavier skin.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Severe and early hair loss may indicate a higher risk of heart disease.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Mutations in the AR gene cause hair thinning and loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Dhatryadi Rasayana, an Ayurvedic herbal mix, may be a safe and effective way to prevent premature hair greying.

Herbal treatments can help with hair problems, but more research is needed.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.